GLP-1 medications have quickly become one of the most talked-about topics in healthcare—and they raise important questions for clinicians caring for patients with substance use disorders. In the first episode of the Governor’s Institute’s new Hot Topics series, Dr. Michael Baca-Atlas joins us for a practical conversation about GLP-1s and what clinicians should know.
Each episode explores a timely clinical topic related to substance use disorders and highlights three key takeaways clinicians can put into practice. In upcoming episodes, we’ll take a closer look at cannabis, Kratom, 7-OH, and perinatal substance use disorder.
Michael Baca-Atlas, MD, FASAM, completed his undergraduate work at the University of Maryland, College Park, and medical school at the University of Maryland School of Medicine. He completed his Family Medicine residency at UNC as well as an Addiction Medicine fellowship at UNC in the Department of Psychiatry. He serves as the associate medical director for the
Tobacco Treatment Program as well as a medical consultant for UNC Horizons, a program that serves women, including those who are pregnant or parenting with substance use disorders. He serves as medical director of UNC REACH Enhanced Primary Care where he sees patients with serious mental illness and substance use disorders. He also serves as an attending on the inpatient family medicine
service at UNC Hospitals Hillsborough Campus. He teaches addiction medicine fellows, family medicine/psychiatry/nurse practitioner residents, and medical and nurse practitioner students in various clinical settings.
Send us Fan Mail
Thanks for listening! Get more of our addiction medicine-related content and learn about the work we do with Service Members, Veterans, and Their Families at our YouTube Page - youtube.com/govinst.